Thomas Benda, MD
Otolaryngology · Dubuque, IANPI 1003897554
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $408 and has fallen 93.2% since, to $28 in 2025. That places this record below the midpoint for otolaryngology clinicians in IA, where the typical reported total is $776.
Across 37 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$141
- Alk-abello, Inc$90
- AstraZeneca$83
- Arrinex, Inc.$73
- Smith+Nephew$72
- Aerin Medical Inc.$65
- plus $351 from 11 others
What the payments were for
- Food & beverage$875100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 4 | $141 |
| Alk-abello, Inc | 5 | $90 |
| AstraZeneca | 1 | $83 |
| Arrinex, Inc. | 1 | $73 |
| Smith+Nephew | 4 | $72 |
| Aerin Medical Inc. | 6 | $65 |
| Convatec Inc. | 2 | $57 |
| Optinose US, Inc. | 3 | $51 |
| Intersect ENT, Inc. | 2 | $44 |
| Acclarent, Inc | 1 | $39 |
| Sanofi | 2 | $37 |
| KARL Storz Endoscopy-america | 1 | $33 |
| Neurent Medical Limited | 1 | $28 |
| Medtronic | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $16 |
| GSK | 1 | $14 |
| Covidien LP | 1 | $11 |
How this compares
$875 in reported general payments places this provider in the 50th percentile of 103 otolaryngology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $41,896 |
| Ipratropium Bromide | 209 | $7,004 |
| Fluticasone Propionate | 365 | $4,156 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $2,868 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 19 | $2,364 |
| Ofloxacin | 42 | $1,453 |
| Azelastine Hcl | 23 | $541 |
| Doxycycline Monohydrate | 37 | $492 |
| Omeprazole | 61 | $460 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $400 |
| Montelukast Sodium | 51 | $342 |
| Clotrimazole | 12 | $330 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $316 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 27 | $248 |
| CefuroximeCefuroxime Axetil | 17 | $166 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Dubuque
- Tyler Willman SrDubuque$1K
- Daniel GivensDubuque$1K
- Gregory WhiteDubuque$634
- Thomas HeinemanCedar Rapids$373K
- Bruce GantzIowa City$170K
- Nancy BaumanIowa City$31K
- Simon WrightWest Des Moines$21K
- Robert PettisOskaloosa$10K
- Brian AndrewsIowa City$9K
- Douglas HoisingtonWest Des Moines$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.